Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam
-
Published:2023-10-28
Issue:1
Volume:22
Page:
-
ISSN:1475-2875
-
Container-title:Malaria Journal
-
language:en
-
Short-container-title:Malar J
Author:
Cao Van Anh Thi,Nguyen Thieu Quang,Le Quyen Duong,Boon Wouter P. C.,Moors Ellen H. M.,Dondorp Arjen M.,de Haan Freek,Amaratunga Chanaki
Abstract
Abstract
Background
This study investigates the processes regarding changing malaria treatment policies in Vietnam. Moreover, it explores the feasibility of introducing triple artemisinin-based combination therapy (TACT) in Vietnam to support the national malaria control and elimination plan.
Methods
Data were collected via 12 in-depth interviews with key stakeholders, combined with a review of policy documents.
Results
TACT is considered as a useful backup strategy in case future treatment failures with current artemisinin-based combination therapy (ACT) would occur. Moreover, TACT is also considered as a promising strategy to prevent the re-establishment of malaria. However, regulatory procedures and implementation timelines for TACT were expected to be lengthy. Therefore, strategies to engage national decision-makers, regulators, and suppliers should be initiated soon, stipulating the benefits of TACT deployment. In Vietnam, a procedure to apply for an import permit without registration that has previously been applied to the introduction of artesunate-pyronaridine was proposed to accelerate the introduction of TACT. Global-level support through the World Health Organization recommendations and prequalification were considered critical for supporting the introduction of TACT in Vietnam.
Conclusions
Appropriate approach strategies and early stakeholder engagement will be needed to accelerate the introduction of TACT in Vietnam.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference29 articles.
1. National Institute of Malariology Parasitology and Entomology (NIMPE). Annual Report for Malaria Control and Elimination 2022. Hanoi, 2023.
2. Vietnamese Ministry of Health. National Strategic Plan on Malaria Control and Elimination 2021–2025. Hanoi, 2020.
3. Hien TT, Dolecek C, Mai PP, Dung NT, Truong NT, An DTH, et al. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet. 2004;363:18–22.
4. Vietnam Ministry of Health. National Guideline of Malaria Diagnosis and Treatment. Hanoi, 2007.
5. WHO. Artemisinin resistance and artemisinin-based combination therapy efficacy: status report. Geneva: World Health Organization; 2018.